Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06848166 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CHROnic Migraine Embolization

Study acronym: CHROME
StatusRecruiting
PhaseNot applicable
Started2024-10-17
View on ClinicalTrials.gov ↗
To evaluate the effectiveness and safety of middle meningeal artery (MMA) embolization using non-adhesive materials SQUID 12 and SQUID 18 as a treatment method for patients with chronic resistant migraine.

Amendment history 5 changes detected by DataLookout

2026-09-12
notable
Trial status changed: Enrolling by Invitation → Recruiting
2026-09-11
notable
Trial status changed: Recruiting → Enrolling by Invitation
2026-09-11
notable
Phase changed: Early Phase 1 → not applicable
2026-09-11
critical
Primary completion pushed: 2026-10 → 2028-04
2026-09-11
minor
Completion pushed: 2027-05 → 2029-05
Trial Details
NCT Number NCT06848166
Lead Sponsor Vedanta University Clinic
Conditions Chronic Migraine Headache
Enrollment 30 participants
Start Date 2024-10-17
Primary Completion 2028-04 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2026-09-11